stocktools
Offerings // Acurx Pharmaceuticals, Inc.

ACXP offering history

Every offering-related filing in Acurx Pharmaceuticals, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 237 filings back to Apr 3, 2018.

Last executed offering
Apr 16, 2026
424B5 — priced deal (shares or notes)
Last registration (announced)
May 4, 2026
S-1 — capacity, not a sale
Executed, last 12 months
2
424B pricings + 8-K 3.02 sales
Registered, last 12 months
5
S-1/S-3/F-series registrations
DateFilingWhat it means
May 12, 2026424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
May 12, 2026424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
May 11, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
May 11, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
May 4, 2026S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
May 4, 2026S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Apr 16, 2026424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Apr 16, 20268-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Feb 11, 2026424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Feb 11, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Feb 2, 2026S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Jan 6, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Dec 30, 2025S-3/A →REGISTEREDS-3/A registration — capacity to sell shares, not a sale yet
Nov 10, 2025424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Oct 20, 2025S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Jul 23, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jul 15, 2025S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Jul 9, 2025S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Jun 20, 20258-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
May 29, 2025424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
May 29, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
May 21, 2025S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
May 8, 20258-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Apr 14, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Apr 4, 2025S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Mar 19, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Mar 10, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Mar 10, 20258-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Feb 6, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jan 31, 2025S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Jan 7, 20258-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Jan 7, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jan 6, 2025424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Apr 17, 2024RW →WITHDRAWNRegistration withdrawn
Apr 2, 2024FWP →MARKETINGFree-writing prospectus — offering being marketed
Mar 29, 2024S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Mar 18, 2024S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Nov 15, 2023424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jul 13, 2023424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Jul 10, 2023EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
ACXP offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full ACXP workspace →
ACXP offering FAQ

When did ACXP last execute an offering?

Per SEC filings, Acurx Pharmaceuticals, Inc.'s most recent priced offering document is a 424B5 filed 2026-04-16. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did ACXP last announce or register an offering?

The most recent registration is a S-1 filed 2026-05-04. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.